Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University Graduate School of Medicine and Dental Sciences, Tokyo, Japan.
Invest Ophthalmol Vis Sci. 2013 May 7;54(5):3240-9. doi: 10.1167/iovs.12-11483.
To determine whether retinal pigment epithelial (RPE) cells can inhibit mature dendritic cells (mDCs).
Cultured RPE cells were established from C57BL/6 mice. DCs were established from bone marrow cells of normal mice, and mDCc were induced by culture in medium containing granulocyte macrophage-colony-stimulating factor (GM-CSF) and IL-4 in the presence of lipopolysaccharide and TNF-α. Activation of mDCs was assessed by a proliferation assay and ELISA to measure the production of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-12p40). Expression of major histocompatibility complex (MHC) class II, CD11c, and costimulatory molecules such as CD80, CD86, programmed cell death 1 ligand 1 (PD-L1), and PD-L2 on mDCs or RPE-exposed mDCs was evaluated by immune staining and flow cytometry. Production of IL-1 receptor antagonist (IL-1Ra) by RPE cells was evaluated by oligonucleotide microarray or ELISA. Anti-IL-1Ra neutralizing antibodies or RPE cells from IL-1Ra knockout donors were used for the assay.
Cultured RPE cells greatly suppressed the activation of mDCs, especially the production of pro-inflammatory cytokines, and the expression of cell-surface molecules. Moreover, RPE cells significantly suppressed mixed lymphocyte reactions by mDCs. In an examination of immunoregulatory candidate molecules, RPE cells expressed much higher levels of IL-1Ra as compared with control cells, and RPE cells pretreated with recombinant TNF-α and/or IL-1β produced high levels of IL-1Ra. RPE cells in the presence of anti-IL-1Ra antibodies, but not other candidate factors, failed to suppress activation by mDCs. In addition, RPE cells from IL-1Ra null donors failed to suppress mDC activation.
Our results suggest that ocular resident cells can produce pro-inflammatory cytokine antagonist that suppresses antigen-presenting cell activation.
确定视网膜色素上皮 (RPE) 细胞是否能抑制成熟树突状细胞 (mDC)。
从小鼠的 C57BL/6 建立 RPE 细胞培养。从正常小鼠的骨髓细胞中建立 DC,通过在含有粒细胞巨噬细胞集落刺激因子 (GM-CSF) 和白细胞介素-4 的培养基中培养,同时加入脂多糖和肿瘤坏死因子-α诱导 mDC。通过增殖试验和酶联免疫吸附试验测量促炎细胞因子 (TNF-α、IL-1β 和 IL-12p40) 的产生来评估 mDC 的激活。通过免疫染色和流式细胞术评估 mDC 或暴露于 RPE 的 mDC 上主要组织相容性复合体 (MHC) Ⅱ类、CD11c 和共刺激分子(如 CD80、CD86、程序性细胞死亡配体 1 [PD-L1] 和 PD-L2)的表达。通过寡核苷酸微阵列或酶联免疫吸附试验评估 RPE 细胞产生白细胞介素-1 受体拮抗剂 (IL-1Ra)。使用抗 IL-1Ra 中和抗体或来自 IL-1Ra 敲除供体的 RPE 细胞进行测定。
培养的 RPE 细胞大大抑制了 mDC 的激活,尤其是促炎细胞因子的产生和细胞表面分子的表达。此外,RPE 细胞显著抑制了 mDC 引起的混合淋巴细胞反应。在检查免疫调节候选分子时,与对照细胞相比,RPE 细胞表达了更高水平的 IL-1Ra,并且用重组 TNF-α和/或 IL-1β预处理的 RPE 细胞产生了高水平的 IL-1Ra。在用抗 IL-1Ra 抗体处理的 RPE 细胞中,但不是用其他候选因子处理的细胞,未能抑制 mDC 的激活。此外,来自 IL-1Ra 缺失供体的 RPE 细胞未能抑制 mDC 的激活。
我们的结果表明,眼部常驻细胞可以产生抑制抗原呈递细胞激活的促炎细胞因子拮抗剂。